Related Experiment Video
Updated: Jun 30, 2026

Assessing Leukocyte-endothelial Interactions Under Flow Conditions in an Ex Vivo Autoperfused Microflow Chamber Assay
Published on: December 30, 2014
Instability of leukocyte aggregation: lack of evidence for leukoembolization during various states of inflammation
R Fadilah1, S Berliner, I Yuli
1Department of Internal Medicine "D", Beilinson Medical Center, Petah Tikva, Israel.
Abstract:
This study centers on the question of whether the phenomenon of leukocyte aggregation, which is typical to inflammatory conditions, is pathogenic per se. We examined patients and laboratory animals in whom the presence of aggregated leukocytes in the peripheral blood was documented by direct visualization and where, despite the presence of aggregated leukocytes, neither the patients nor the laboratory animals showed clinical or pathological evidence for leukoembolization. Our in vitro findings about the reversibility of the phenomenon of leukocyte aggregation help to explain the above-mentioned observations as well as the well-known daily clinical experience that, despite complement activation and other aggregatory stimuli, there is no clinical or pathological evidence for leukoembolization.
Related Concept Videos
Inflammation
Intracellular Signaling Affects Focal Adhesions
Some...
Disorders of Leukocytes
Leukopenia may result from bone marrow disorders, autoimmune diseases, and infectious diseases. For example, conditions such as multiple myeloma and aplastic anemia can impair the bone marrow's ability to produce adequate leukocytes. Similarly, autoimmune diseases like lupus and viral infections such as HIV can prompt the immune system...
Acute Inflammation II: Cellular Phase
Acute Inflammation III: Local and Systemic Effects
Chronic Inflammation: Introduction

